• Biocon Pharma Limited has obtained approval for its Abbreviated New Drug Application (ANDA) for Everolimus Tablets from the US FDA.
  • The approved strengths are 0.25 mg, 0.5 mg, 0.75 mg…

Unlock the Full Filing And Lot More

Access premium insights and stay ahead of the market with Dzambhala NodeX.

Try Now For Free
#BIOCON #Corporate Action

Join the vibrant privacy-ensured Dzambhala community on